Prelunch Symposium
Pre-Luncheon Symposium 1
Shaping the New Era of Pathology through Digital and Computational Innovation
- Multimodal-computational digital pathology for successful cancer screening-diagnostics and treatment of a deadly disease: an academic-industrial cooperation: Béla Molnár
- Pathology 4.0 and Beyond: Digital Pathology, AI and 3D Imaging: Yosep Chong
Speakers
Béla Molnár
M.D., D.Sc.
3DHISTECH
Yosep Chong
M.D., Ph.D, MIAC
The Catholic University of Korea
College of Medicine
Pre Luncheon Symposium 2
Day 2 : Saturday 11th Oct, 2025
| 12:15 - 13:00 PM | (Hall A & B)
Digital Revolution in Pathology: Keys to Success
Brief Intro:
This symposium highlights how leading institutions in Asia are redefining
diagnostic practices with
digital pathology.
ASAN Medical Center in Seoul, Korea’s largest private hospital, producing
nearly 900,000 slides
annually has shifted to a fully digital workflow, improving diagnosis speed,
accuracy, and
collaboration. They employ AI algorithms and develop applications to enhance
clinical
outcomes and
efficiency.
In India, Dr. Lal PathLabs has adopted digital pathology to maximize
productivity and diagnostic
precision, supporting increased caseloads and enabling multidisciplinary
consultation.
Participants will gain practical insights into the benefits and keys to
successful implementation of
digital pathology.
Speakers
Prof. Heounjeong Go
MD, PhD, Associate Professor, Asan Medical Center
Republic of Korea
Dr. Reena Nakra
MD, Principal Director, Lab Management & Technical Excellence, Dr. Lal Pathlabs
New Delhi, India Pre Luncheon Symposium 3
Day 3 : Sunday 12th Oct, 2025
| 12:15 - 13:00 PM | (Hall A & B)
Theme:
- Leveraging Computational Pathology to Enhance Clinical Decision-Making: Dr. Kumar Prabhash
- Multi-reader Study on Accuracy and Concordance of Pathologists and AI-Assisted HER2 IHC Assessment in Breast Cancer, Including HER2 Ultralow Scoring: Dr. Chee Leong Cheng
Speakers
Dr. Kumar Prabhash
Tata Memorial Hospital, Mumbai
India
Dr. Chee Leong Cheng
Singapore General Hospital
SingaporeBreakfast Symposium
Breakfast Industry Symposium 1
Day 2 : Saturday 11th Oct, 2025
| 08:15 - 9:00 AM
| (Hall A & B)
- From Variability to Validation: AI-Driven Digital Cytology for Accurate, Scalable Screening for Cervical Cancer: Dr. Anita Nangia
Speaker
Dr. Anita Nangia
Medical Director, OptraSCAN Inc Pvt Ltd
IndiaBreakfast Industry Symposium 2
Day 3 : Sunday 12th Oct, 2025
| 08:15 - 9:00 AM
| (Hall A & B)
Integrating Spatial tech, multiplex IHC/IF into Pathology Workflow
- Spatial Single-Cell Profiling: Any Scale, Any Size, All at Once: Dr. Joe Yeong
MGI Tech Team
- Video Play of DNBSEQ-G400RS FluoXpert
- G400RS FluoXpert Proposal to ASDP board members
Panel discussion: How can pathologists better adopt or even lead spatial tech and multiplex IHC/IF research & translation?
Moderator: Dr. Joe Yeong, Singapore General Hospital, Singapore
Panellist: Inti Zlobec (Switzerland), Manu Sebastian (USA) Andrey Bychkov (Japan), Rajiv Kaushal (India) + Dr. Sharath Chandra (India)
Speaker
Dr. Joe Yeong
Singapore General Hospital
SingaporeEvening Symposium
Evening Industry Symposium 1
Day 1 : Friday 10th Oct, 2025
| 17:15 - 18:00 PM
| (Hall A)
Revolutionize Digital Pathology using AI on the AWS Cloud
Theme :
Unlike radiology, efficiency gains for pathologists are not as important as reducing variability and improving treatment decisions for patients. For this reason, it is pertinent to evaluate the use of AI to better risk stratify patients. This can potentially inform precision therapy and determine which patients will benefit from chemotherapy and which will not and be spared the harmful side effects. At >2 GB per sample, the digital pathology data is very large and requires a cloud-based infrastructure to build and operate foundation models at scale. Come join me to understand and witness how AWS cloud is revolutionizing use of AI for Digital Pathology.
Speaker
Mainak Chakraborty
Senior Solutions Architect, AWS Healthcare and Life Sciences
IndiaEvening Industry Symposium 2
Day 2 : Saturday 11th Oct, 2025
| 17:30 - 18:15 PM
| (Hall A)
Innovation To Impact: Digital Pathology & Al Democratising Precision Oncology
While NGS is becoming the gold standard in cancer care, accessibility is impacted due to economic constraints especially among self-pay patients. 1Cell.Ai has developed a proprietary product called OncoPredikt using AI/ML to predict genomic biomarkers from histopathology images, and which significantly reduces the cost burden, making the technology affordable to all.
- Introduction to 1Cell.Ai: Mr. Mohan Uttarwar
- Technology platforms & their applications: Dr. Jayendra Shinde
- Followed by Panel Discussion: Moderator - Mr. Mohan Uttarwar
Panellists: Dr. Sandip M. Bipte (Mumbai), Dr. Liron Pantanowitz (USA), Dr. Rajendra Singh (USA) Dr. Deepak Mishra (Kolkata), Dr. Ayushi Jain (Mumbai)
Speakers
Mr. Mohan Uttarwar
Co Founder & CEO, 1Cell.Ai
India
Dr. Jayendra Shinde
GM-Digital Data Products 1Cell.Ai
India